Pacira BioSciences, Inc. (PCRX)

Last Closing Price: 25.93 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Pacira BioSciences, Inc. (PCRX) had Net Income of $4.81M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$168.92M
Net Income
$4.81M
$34.31M
$134.62M
$166.93M
$1.99M
$6.72M
$8.71M
$8.71M
$4.81M
$4.81M
$4.81M
$4.81M
$1.99M
$24.02M
46.27M
46.53M
$0.10
$0.10
Balance Sheet Financials
$759.96M
$164.45M
$826.71M
$1.59B
$314.73M
$381.29M
$473.40M
$788.13M
$798.54M
$342.05M
$798.54M
46.28M
Cash Flow Statement Financials
$35.46M
$-25.63M
$-2.99M
$276.77M
$283.61M
$6.84M
$14.55M
--
--
Fundamental Metrics & Ratios
2.41
--
--
0.32
0.73
79.69%
1.18%
1.18%
--
5.15%
2.85%
$26.91M
--
--
--
0.11
0.26
1.61
55.81
0.60%
1.41%
0.30%
0.41%
$17.25
$0.58
$0.76